Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt Lymphoma

Burkitt lymphoma (BL) accounts for most pediatric non-Hodgkin lymphomas, being less common but significantly more lethal when diagnosed in adults. Much of the knowledge of the genetics of BL thus far has originated from the study of pediatric BL (pBL), leaving its relationship to adult BL (aBL) and other adult lymphomas not fully explored. We sought to more thoroughly identify the somatic changes that underlie lymphomagenesis in aBL and any molecular features that associate with clinical disparities within and between pBL and aBL. Through comprehensive whole-genome sequencing of 230 BL and 295 diffuse large B-cell lymphoma (DLBCL) tumors, we identified additional significantly mutated genes, including more genetic features that associate with tumor Epstein-Barr virus status, and unraveled new distinct subgroupings within BL and DLBCL with 3 predominantly comprising BLs: DGG-BL (DDX3X, GNA13, and GNAI2), IC-BL (ID3 and CCND3), and Q53-BL (quiet TP53). Each BL subgroup is characterized by combinations of common driver and noncoding mutations caused by aberrant somatic hypermutation. The largest subgroups of BL cases, IC-BL and DGG-BL, are further characterized by distinct biological and gene expression differences. IC-BL and DGG-BL and their prototypical genetic features (ID3 and TP53) had significant associations with patient outcomes that were different among aBL and pBL cohorts. These findings highlight shared pathogenesis between aBL and pBL, and establish genetic subtypes within BL that serve to delineate tumors with distinct molecular features, providing a new framework for epidemiologic, diagnostic, and therapeutic strategies.

Citing Articles

Circulating tumor DNA in lymphoma: technologies and applications.

Fu L, Zhou X, Zhang X, Li X, Zhang F, Gu H J Hematol Oncol. 2025; 18(1):29.

PMID: 40069858 PMC: 11900646. DOI: 10.1186/s13045-025-01673-7.

Comparison of Nanopore with Illumina Whole Genome Assemblies of the Epstein-Barr Virus in Burkitt Lymphoma.

Kim I, Kim Jr I, Fola A, Puig E, Maina T, Hui S medRxiv. 2025; .

PMID: 40061313 PMC: 11888525. DOI: 10.1101/2025.02.21.25322471.

Genetic regulation of TERT splicing affects cancer risk by altering cellular longevity and replicative potential.

Florez-Vargas O, Ho M, Hogshead M, Papenberg B, Lee C, Forsythe K Nat Commun. 2025; 16(1):1676.

PMID: 39956830 PMC: 11830802. DOI: 10.1038/s41467-025-56947-y.

Patterns of incident Burkitt lymphoma during the HIV epidemic among the Black African and White population in South Africa.

Metekoua C, Ruffieux Y, Mwansa-Kambafwile J, Kellett P, Egger M, Muchengeti M Br J Cancer. 2025; 132(5):462-468.

PMID: 39809970 PMC: 11876306. DOI: 10.1038/s41416-024-02937-8.

Genetic regulation of splicing contributes to reduced or elevated cancer risk by altering cellular longevity and replicative potential.

Florez-Vargas O, Ho M, Hogshead M, Lee C, Papenberg B, Forsythe K medRxiv. 2025; .

PMID: 39802763 PMC: 11722454. DOI: 10.1101/2024.11.04.24316722.

References

Chapuy B, Stewart C, Dunford A, Kim J, Kamburov A, Redd R . Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018; 24(5):679-690. PMC: 6613387. DOI: 10.1038/s41591-018-0016-8. View

Wright G, Huang D, Phelan J, Coulibaly Z, Roulland S, Young R . A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell. 2020; 37(4):551-568.e14. PMC: 8459709. DOI: 10.1016/j.ccell.2020.03.015. View

Hubschmann D, Kleinheinz K, Wagener R, Bernhart S, Lopez C, Toprak U . Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas. Leukemia. 2021; 35(7):2002-2016. PMC: 8257491. DOI: 10.1038/s41375-021-01251-z. View

. Pan-cancer analysis of whole genomes. Nature. 2020; 578(7793):82-93. PMC: 7025898. DOI: 10.1038/s41586-020-1969-6. View

Horn H, Kohler C, Witzig R, Kreuz M, Leich E, Klapper W . Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2. Haematologica. 2018; 103(7):1182-1190. PMC: 6029545. DOI: 10.3324/haematol.2017.181024. View

Zhou P, Blain A, Newman A, Zaka M, Chagaluka G, Adlar F . Sporadic and endemic Burkitt lymphoma have frequent mutations but distinct hotspots in the AKT recognition motif. Blood Adv. 2019; 3(14):2118-2127. PMC: 6650741. DOI: 10.1182/bloodadvances.2018029546. View

Bellan C, Lazzi S, Hummel M, Palummo N, de Santi M, Amato T . Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood. 2005; 106(3):1031-6. DOI: 10.1182/blood-2005-01-0168. View

Lopez C, Kleinheinz K, Aukema S, Rohde M, Bernhart S, Hubschmann D . Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat Commun. 2019; 10(1):1459. PMC: 6440956. DOI: 10.1038/s41467-019-08578-3. View

Richter J, John K, Staiger A, Rosenwald A, Kurz K, Michgehl U . Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br J Haematol. 2021; 196(3):681-689. DOI: 10.1111/bjh.17874. View

10.

Alaggio R, Amador C, Anagnostopoulos I, Attygalle A, de Oliveira Araujo I, Berti E . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36(7):1720-1748. PMC: 9214472. DOI: 10.1038/s41375-022-01620-2. View

11.

Salaverria I, Zettl A, Bea S, Hartmann E, Dave S, Wright G . Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma. Haematologica. 2008; 93(9):1327-34. PMC: 9009721. DOI: 10.3324/haematol.13071. View

12.

Coyle K, Hillman T, Cheung M, Grande B, Bushell K, Arthur S . Shared and distinct genetic features in human and canine B-cell lymphomas. Blood Adv. 2022; 6(11):3404-3409. PMC: 9198934. DOI: 10.1182/bloodadvances.2021006429. View

13.

Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B . Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012; 44(12):1316-20. DOI: 10.1038/ng.2469. View

14.

de Leval L, Alizadeh A, Bergsagel P, Campo E, Davies A, Dogan A . Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022; 140(21):2193-2227. PMC: 9837456. DOI: 10.1182/blood.2022015854. View

15.

Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, Rosenwald A . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000; 403(6769):503-11. DOI: 10.1038/35000501. View

16.

McGoldrick S, Mutyaba I, Adams S, Larsen A, Krantz E, Namirembe C . Survival of children with endemic Burkitt lymphoma in a prospective clinical care project in Uganda. Pediatr Blood Cancer. 2019; 66(9):e27813. DOI: 10.1002/pbc.27813. View

17.

Schmitz R, Wright G, Huang D, Johnson C, Phelan J, Wang J . Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N Engl J Med. 2018; 378(15):1396-1407. PMC: 6010183. DOI: 10.1056/NEJMoa1801445. View

18.

Lacy S, Barrans S, Beer P, Painter D, Smith A, Roman E . Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood. 2020; 135(20):1759-1771. PMC: 7259825. DOI: 10.1182/blood.2019003535. View

19.

Wagener R, Aukema S, Schlesner M, Haake A, Burkhardt B, Claviez A . The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma. Genes Chromosomes Cancer. 2015; 54(9):555-64. DOI: 10.1002/gcc.22268. View

20.

Morin R, Arthur S, Hodson D . Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?. Br J Haematol. 2021; 196(4):814-829. DOI: 10.1111/bjh.17811. View